GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
18.15
-0.66 (-3.51%)
At close: Oct 16, 2026, 4:00 PM EDT
18.47
+0.32 (1.76%)
Pre-market: Oct 19, 2026, 7:42 AM EDT
GH Research Market Cap
GH Research has a market cap or net worth of $1.25 billion as of October 16, 2026. It is the 8,942nd most valuable company in the world and the 2,076th biggest in the United States. Its market cap has increased by 38.52% in one year.
Market Cap
1.25B
Enterprise Value
883.57M
1-Year Change
38.52%
Global Rank
Country Rank
#2,076 United States
Category
ChartMarket Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has increased from $808.33M to $1.25B, an increase of 54.13%. That is a compound annual growth rate of 8.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 1.25B | 58.15% |
| Dec 31, 2025 | 787.77M | 116.30% |
| Dec 31, 2024 | 364.20M | 20.71% |
| Dec 29, 2023 | 301.72M | -40.33% |
| Dec 30, 2022 | 505.64M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
| Jun 25, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rapport Therapeutics | 1.32B |
| Inhibrx Biosciences | 1.32B |
| ORIC Pharmaceuticals | 1.28B |
| Tyra Biosciences | 1.27B |
| First Tracks Biotherapeutics | 1.23B |
| Nektar Therapeutics | 1.22B |
| Kardigan | 1.22B |
| LB Pharmaceuticals | 1.19B |